PhaseBio, Osmotica price IPOs well below range

PhaseBio, Osmotica price IPOs well below range

Source: 
BioCentury
snippet: 

Cardiopulmonary company PhaseBio Pharmaceuticals Inc. (NASDAQ:PHAS) and neurology and women's health company Osmotica Pharmaceuticals plc (NASDAQ:OSMT) each priced IPOs well below their proposed ranges late Wednesday. PhaseBio trading ended flat at $5 on Thursday, while Osmotica was up $1.15 (17%) to $8.15.